4 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Docetaxel/Pembrolizumab in Head and Neck Squamous Cell CarcinomaHead and Neck Neoplasms, Neoplasms by Site, neoplasmActive, not recruitingPhase 22025-09-12NCT05252429
Safety Evaluation Study for Patients With Aggressive NK-cell LeukemiaHemic and Lymphatic Diseases, Leukemia, Large Granular Lymphocytic, Neoplasms by Histologic Type, T-cell leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasmRecruitingPhase 1 / Phase 22025-04-30NCT05863234
Development of a Patient-Reported Outcome Measure to Assess Recovery After Abdominal SurgeryAbdominal SurgeryActive, not recruitingNot stated2025-04-13NCT03461497
Intracerebral Autologous Stem Cell Therapy for Chronic Stroke PatientsBronchiolitis Obliterans, brain disorder, bronchial disorder, bronchiolitis, bronchiolitis obliterans syndrome, bronchitis, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, cryptogenic organizing pneumonia, graft versus host disease, immune system disorder, ischemic stroke, lung disorder, nervous system disorder, obstructive lung disease, respiratory system disorder, stroke disorder, vascular disorderRecruitingPhase 22025-01-24NCT06752720